Doms Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 20, 2025, 8:53 pm

Competitors of Doms Industries Ltd

All Competitor Stocks of Doms Industries Ltd

Quarterly Result

Last Updated: August 19, 2025, 7:55 pm

Below is a detailed analysis of the quarterly data for Doms Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 562.00 Cr.. The value appears strong and on an upward trend. It has increased from 509.00 Cr. (Mar 2025) to 562.00 Cr., marking an increase of 53.00 Cr..
• For Expenses, as of Jun 2025, the value is 464.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 420.00 Cr. (Mar 2025) to 464.00 Cr., marking an increase of 44.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 88.00 Cr. (Mar 2025) to 99.00 Cr., marking an increase of 11.00 Cr..
• For OPM %, as of Jun 2025, the value is 18.00%. The value appears strong and on an upward trend. It has increased from 17.00% (Mar 2025) to 18.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 21.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 69.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 10.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 51.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 8.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 9.44. The value appears strong and on an upward trend. It has increased from 7.98 (Mar 2025) to 9.44, marking an increase of 1.46.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:29 am

Growth

Last Updated: September 5, 2025, 3:16 pm

Balance Sheet

Last Updated: September 10, 2025, 3:31 pm

Below is a detailed analysis of the balance sheet data for Doms Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 61.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 61.00 Cr..
• For Reserves, as of Mar 2025, the value is 942.00 Cr.. The value appears strong and on an upward trend. It has increased from 754.00 Cr. (Mar 2024) to 942.00 Cr., marking an increase of 188.00 Cr..
• For Borrowings, as of Mar 2025, the value is 212.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 172.00 Cr. (Mar 2024) to 212.00 Cr., marking an increase of 40.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 297.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 204.00 Cr. (Mar 2024) to 297.00 Cr., marking an increase of 93.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,511.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,190.00 Cr. (Mar 2024) to 1,511.00 Cr., marking an increase of 321.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 690.00 Cr.. The value appears strong and on an upward trend. It has increased from 498.00 Cr. (Mar 2024) to 690.00 Cr., marking an increase of 192.00 Cr..
• For CWIP, as of Mar 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2024) to 60.00 Cr., marking an increase of 35.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 759.00 Cr.. The value appears strong and on an upward trend. It has increased from 665.00 Cr. (Mar 2024) to 759.00 Cr., marking an increase of 94.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,511.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,190.00 Cr. (Mar 2024) to 1,511.00 Cr., marking an increase of 321.00 Cr..

Notably, the Reserves (942.00 Cr.) exceed the Borrowings (212.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Doms Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 33.34. This value is within the healthy range. It has increased from 27.75 (Mar 24) to 33.34, marking an increase of 5.59.
• For Diluted EPS (Rs.), as of Mar 25, the value is 33.31. This value is within the healthy range. It has increased from 27.75 (Mar 24) to 33.31, marking an increase of 5.56.
• For Cash EPS (Rs.), as of Mar 25, the value is 46.59. This value is within the healthy range. It has increased from 34.75 (Mar 24) to 46.59, marking an increase of 11.84.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 165.24. It has increased from 138.78 (Mar 24) to 165.24, marking an increase of 26.46.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 165.24. It has increased from 138.78 (Mar 24) to 165.24, marking an increase of 26.46.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 315.16. It has increased from 253.29 (Mar 24) to 315.16, marking an increase of 61.87.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 61.14. This value is within the healthy range. It has increased from 46.61 (Mar 24) to 61.14, marking an increase of 14.53.
• For PBIT / Share (Rs.), as of Mar 25, the value is 49.74. This value is within the healthy range. It has increased from 38.17 (Mar 24) to 49.74, marking an increase of 11.57.
• For PBT / Share (Rs.), as of Mar 25, the value is 47.26. This value is within the healthy range. It has increased from 35.34 (Mar 24) to 47.26, marking an increase of 11.92.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 35.19. This value is within the healthy range. It has increased from 26.31 (Mar 24) to 35.19, marking an increase of 8.88.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 33.34. This value is within the healthy range. It has increased from 25.23 (Mar 24) to 33.34, marking an increase of 8.11.
• For PBDIT Margin (%), as of Mar 25, the value is 19.39. This value is within the healthy range. It has increased from 18.40 (Mar 24) to 19.39, marking an increase of 0.99.
• For PBIT Margin (%), as of Mar 25, the value is 15.78. This value is within the healthy range. It has increased from 15.06 (Mar 24) to 15.78, marking an increase of 0.72.
• For PBT Margin (%), as of Mar 25, the value is 14.99. This value is within the healthy range. It has increased from 13.95 (Mar 24) to 14.99, marking an increase of 1.04.
• For Net Profit Margin (%), as of Mar 25, the value is 11.16. This value exceeds the healthy maximum of 10. It has increased from 10.38 (Mar 24) to 11.16, marking an increase of 0.78.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.57. This value is within the healthy range. It has increased from 9.96 (Mar 24) to 10.57, marking an increase of 0.61.
• For Return on Networth / Equity (%), as of Mar 25, the value is 20.17. This value is within the healthy range. It has increased from 18.80 (Mar 24) to 20.17, marking an increase of 1.37.
• For Return on Capital Employeed (%), as of Mar 25, the value is 23.90. This value is within the healthy range. It has increased from 23.54 (Mar 24) to 23.90, marking an increase of 0.36.
• For Return On Assets (%), as of Mar 25, the value is 13.31. This value is within the healthy range. It has increased from 12.86 (Mar 24) to 13.31, marking an increase of 0.45.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.15. This value is within the healthy range. It has increased from 0.14 (Mar 24) to 0.15, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.41. It has decreased from 1.68 (Mar 24) to 1.41, marking a decrease of 0.27.
• For Current Ratio (X), as of Mar 25, the value is 2.68. This value is within the healthy range. It has decreased from 2.99 (Mar 24) to 2.68, marking a decrease of 0.31.
• For Quick Ratio (X), as of Mar 25, the value is 1.54. This value is within the healthy range. It has decreased from 1.90 (Mar 24) to 1.54, marking a decrease of 0.36.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.37. This value is within the healthy range. It has increased from 4.29 (Mar 24) to 7.37, marking an increase of 3.08.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.49. This value is below the healthy minimum of 20. It has increased from 6.08 (Mar 24) to 7.49, marking an increase of 1.41.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.58. This value is below the healthy minimum of 20. It has increased from 4.55 (Mar 24) to 5.58, marking an increase of 1.03.
• For Earning Retention Ratio (%), as of Mar 25, the value is 92.51. This value exceeds the healthy maximum of 70. It has decreased from 93.92 (Mar 24) to 92.51, marking a decrease of 1.41.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.42. This value exceeds the healthy maximum of 70. It has decreased from 95.45 (Mar 24) to 94.42, marking a decrease of 1.03.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 24.66. This value is within the healthy range. It has increased from 16.52 (Mar 24) to 24.66, marking an increase of 8.14.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 15.19. This value is within the healthy range. It has increased from 10.32 (Mar 24) to 15.19, marking an increase of 4.87.
• For Enterprise Value (Cr.), as of Mar 25, the value is 17,491.40. It has increased from 9,294.68 (Mar 24) to 17,491.40, marking an increase of 8,196.72.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.15. This value exceeds the healthy maximum of 3. It has increased from 6.05 (Mar 24) to 9.15, marking an increase of 3.10.
• For EV / EBITDA (X), as of Mar 25, the value is 47.14. This value exceeds the healthy maximum of 15. It has increased from 32.86 (Mar 24) to 47.14, marking an increase of 14.28.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.14. This value exceeds the healthy maximum of 3. It has increased from 6.15 (Mar 24) to 9.14, marking an increase of 2.99.
• For Retention Ratios (%), as of Mar 25, the value is 92.50. This value exceeds the healthy maximum of 70. It has decreased from 93.91 (Mar 24) to 92.50, marking a decrease of 1.41.
• For Price / BV (X), as of Mar 25, the value is 17.44. This value exceeds the healthy maximum of 3. It has increased from 11.61 (Mar 24) to 17.44, marking an increase of 5.83.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.14. This value exceeds the healthy maximum of 3. It has increased from 6.15 (Mar 24) to 9.14, marking an increase of 2.99.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness